OLIVIA LOGAN: Open Payments
NPI 1972695849 · NORTH ATTLEBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 81 payments from 24 companies in 2025. Trend: 2023 $1,312 · 2024 $1,549 · 2025 $1,793
Food & beverage: $1,701Education: $92
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $280 |
| Ferring Pharmaceuticals Inc. | 5 | $256 |
| Sumitomo Pharma America, Inc. | 16 | $232 |
| Endo USA, Inc. | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $94 |
| AstraZeneca Pharmaceuticals LP | 2 | $91 |
| Dendreon Pharmaceuticals LLC | 4 | $89 |
| Astellas Pharma US Inc | 3 | $62 |
| 180 Medical, Inc. | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55 |
Products named: ERLEADA, ADSTILADRIN, GEMTESA, Nubeqa, LYNPARZA, PROVENGE, Xtandi, ORGOVYX.
Industry payments across MA — which companies pay providers there.
